This week, Jen and Michael were delighted to speak with Dr Michael Winlo. Michael is Managing Director at Emyria, a data-driven, drug development and clinical services company focused on improving care of patients with unmet needs. Emyria leverages the clinical evidence created with patients to launch and register novel drug development and treatment programs with global regulators.

Michael is also a Director at Linear Clinical Research - Perth’s only dedicated early phase cancer and clinical trial unit. Michael was previously CEO at Linear which, under his leadership, was the first site in Australia to complete a comprehensive digital transformation. Prior to Linear, Michael lived and worked in Silicon Valley leading the Health team at Palantir working with major healthcare institutions in the US and UK to solve complex data integration and analysis challenges. Michael is a medical doctor with an MBA from Stanford and holds several data analysis patents.

You can learn more about Michael and Emyria here:

https://www.linkedin.com/in/mwinlo

Transcript: https://go.unimelb.edu.au/v6pe